598 related articles for article (PubMed ID: 16836263)
21. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
Takahashi M; Koga M; Yokoyama K; Yuki N
J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
[TBL] [Abstract][Full Text] [Related]
22. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
[TBL] [Abstract][Full Text] [Related]
23. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
24. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
Li H; Yuan J; Shen B; Sun X; Hao H
Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
[TBL] [Abstract][Full Text] [Related]
25. Detection of Campylobacter jejuni/C.coli infection in patients with Guillain-Barré syndrome by serology and culture.
Hariharan H; Naseema K; Kumaran C; Shanmugam J; Nair MD; Radhakrishnan K
New Microbiol; 1996 Jul; 19(3):267-71. PubMed ID: 8841044
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris].
Sivadon V; Orlikowski D; Rozenberg F; Quincampoix JC; Caudie C; Durand MC; Fauchère JL; Sharshar T; Raphaël JC; Gaillard JL
Pathol Biol (Paris); 2005; 53(8-9):536-8. PubMed ID: 16084033
[TBL] [Abstract][Full Text] [Related]
27. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
[TBL] [Abstract][Full Text] [Related]
28. [Guillain-Barré syndrome secondary to Mycoplasma pneumoniae infection].
Villanueva JE; Marteles MS; Allué RM
Neurologia; 2007 Oct; 22(8):556. PubMed ID: 18000765
[No Abstract] [Full Text] [Related]
29. Case records of the Massachusetts General Hospital. Case 39-1999. A 74-year-old woman with acute, progressive paralysis after diarrhea for one week.
N Engl J Med; 1999 Dec; 341(26):1996-2003. PubMed ID: 10607818
[No Abstract] [Full Text] [Related]
30. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity and specificity of serology in determining recent acute Campylobacter infection.
Taylor BV; Williamson J; Luck J; Coleman D; Jones D; McGregor A
Intern Med J; 2004 May; 34(5):250-8. PubMed ID: 15151671
[TBL] [Abstract][Full Text] [Related]
32. [Campylobacter jejuni infection and Guillain-Barré syndrome]].
Humbel RL
Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):283-7. PubMed ID: 20882747
[No Abstract] [Full Text] [Related]
33. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
[TBL] [Abstract][Full Text] [Related]
34. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
35. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
36. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues.
Kuroki S; Saida T; Nukina M; Haruta T; Yoshioka M; Kobayashi Y; Nakanishi H
Ann Neurol; 1993 Mar; 33(3):243-7. PubMed ID: 8498807
[TBL] [Abstract][Full Text] [Related]
37. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Koga M; Yuki N
Neurology; 2007 Oct; 69(17):1727-8; author reply 1728. PubMed ID: 17954791
[No Abstract] [Full Text] [Related]
38. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome.
Mishu B; Ilyas AA; Koski CL; Vriesendorp F; Cook SD; Mithen FA; Blaser MJ
Ann Intern Med; 1993 Jun; 118(12):947-53. PubMed ID: 8489109
[TBL] [Abstract][Full Text] [Related]
39. Guillain-Barré syndrome and its treatment.
Douglas MR; Winer JB
Expert Rev Neurother; 2006 Oct; 6(10):1569-74. PubMed ID: 17078795
[TBL] [Abstract][Full Text] [Related]
40. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
